Cardinal Health Raises 2025 Profit Outlook Again, Helped By Strong Drug Distribution Business
Portfolio Pulse from Vandana Singh
Cardinal Health Inc. (NYSE:CAH) reported strong Q1 2025 results, with adjusted EPS of $1.88 beating expectations. Despite a 4% sales decrease, the company raised its 2025 profit outlook, driven by its Pharmaceutical and Specialty Solutions segment. CAH stock rose 2.97% in premarket trading.
November 01, 2024 | 12:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cardinal Health reported a strong Q1 2025 with adjusted EPS of $1.88, beating expectations. Despite a 4% sales decrease, the company raised its 2025 profit outlook, driven by its Pharmaceutical and Specialty Solutions segment. CAH stock rose 2.97% in premarket trading.
Cardinal Health's strong Q1 2025 performance, particularly in the Pharmaceutical and Specialty Solutions segment, led to a raised profit outlook for 2025. This positive financial news is likely to boost investor confidence, as reflected in the 2.97% premarket stock price increase.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100